Therapeutic effects of curcumin on constipation-predominant irritable bowel syndrome is associated with modulating gut microbiota and neurotransmitters
IntroductionConstipation-predominant irritable bowel syndrome (IBS-C) is a functional bowel disease that affects 10–20% of the population worldwide. Curcumin (CUR) is widely used in traditional Chinese medicine to treat IBS, but its mechanism of action needs further investigation.MethodsIn this stud...
Main Authors: | Xiaoting Tu, Hongyan Ren, Shurui Bu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-12-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1274559/full |
Similar Items
-
Constipation-Predominant Irritable Bowel Syndrome Associated to Hyperprolactinemia
by: C. Seretis, et al.
Published: (2011-09-01) -
Tenapanor in the Treatment of Irritable Bowel Syndrome with Constipation: Discovery, Efficacy, and Role in Management
by: Herekar A, et al.
Published: (2023-06-01) -
The management of constipation-related functional gastrointestinal disorder (constipation-predominant irritable bowel syndrome)
by: Amal F Radwan, et al.
Published: (2015-01-01) -
Prevalence of Subthreshold Depression Among Constipation-Predominant Irritable Bowel Syndrome Patients
by: Norfilza Mohd Mokhtar, et al.
Published: (2020-08-01) -
The effect of biofeedback therapy on dyssynergic constipation in patients with or without Irritable Bowel Syndrome
by: Tannaz Ahadi, et al.
Published: (2014-01-01)